Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Ophthalmol Retina. 2019 Jan 31;3(5):436–443. doi: 10.1016/j.oret.2019.01.016

Figure 2-.

Figure 2-

Fluorescein angiogram demonstrating recurrent neovascularization (arrows) in a patient with retinopathy of prematurity following intravitreal bevacizumab (left) Fluorescein angiogram showing neovascularization (arrow) in a 9-year-old from the untreated cohort presenting with spontaneous vitreous hemorrhage (right)